(1)
Bhavsar, D. . Adverse Event Label Expansion for GLP-1 Medications Due ToOff-‎Label Use: Regulatory Implications and Challenges. IJBAS 2026, 14 (8), 702-709. https://doi.org/10.14419/n99q9v48.